2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF CLINICAL ONCOLOGY J CLIN ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.9
53人评分
我要评分
声誉 9.9 影响力 9.9 速度 9.1 | |||||||||||||||||||||
| 期刊ISSN | 0732-183X | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1527-7755 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 43.4 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：42.85 | |||||||||||||||||||||
| 2024-2025自引率 | 1.8%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 38.2 | |||||||||||||||||||||
| JCI期刊引文指标 | 6.77 | |||||||||||||||||||||
| h-index | 494 | |||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jco.ascopubs.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JCO-ASCOPUBS | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study Author: Zhou, Huaqiang; Zhao, Hongyun; Hou, Xue; Wang, Yongsheng; He, Zhiyong; Li, Yongsheng; Ma, Yuxiang; Zhao, Yuanyuan; Huang, Yan; Chen, Likun; Xiao, Sa; Zhu, Hai; Zhu, Yi; Fang, Wenfeng; Zhang, Li; Yang, Yunpeng Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 10, pp. 893-902. DOI: 10.1200/JCO-25-01929 Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen Imaging Author: Zhang, Yunfeng; Wang, Xing; Hu, Honglin Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 10, pp. 945-946. DOI: 10.1200/JCO-25-02107 Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study Author: Robertson, John F. R.; Gogitidze, Teimuraz; Katashvili, Zaza; Rocha, Juan Enrique Bargallo; Arkania, Ekaterine; Moppett, Iain; Cheung, Kwok-Leung; Nemsadze, Gia; Ajimi, Maxine; Klinowska, Teresa; Lindemann, Justin P. O.; Mathewson, Alastair; Morrow, Christopher J.; Nikolaou, Myria; Scaltriti, Maurizio; Sykes, Andy; Dzagnidze, Giorgi Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 9, pp. 750-761. DOI: 10.1200/JCO-25-01548 International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR Author: Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C.; Minchom, Anna; Pe, Madeline; Peipert, John D.; Snyder, Claire; Symeonides, Stefan N.; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E.; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R.; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Donal; Le Tourneau, Christophe; Lee, J. Jack; Ma, Brigette B. Y.; Marshall, Lynley V.; Patel, Sheetal; Petrie, Joan; Pond, Gregory R.; Prior, Kieran; Rantell, Khadija R.; Reeve, John F.; Solovyeva, Olga; Wages, Nolan A.; Weber, Harald A.; Calvert, Melanie J.; Yap, Christina Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 8, pp. -. DOI: 10.1200/JCO-25-01625 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF CLINICAL ONCOLOGY的语言要求，还能让JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, USA, VA, 22314 | |||||||||||||||||||||
| 出版商 | American Society of Clinical Oncology | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Biweekly | |||||||||||||||||||||
| 出版年份 | 1983 | |||||||||||||||||||||
| 年文章数 | 365点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 24.89% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.70% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约20% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study Author: Zhou, Huaqiang; Zhao, Hongyun; Hou, Xue; Wang, Yongsheng; He, Zhiyong; Li, Yongsheng; Ma, Yuxiang; Zhao, Yuanyuan; Huang, Yan; Chen, Likun; Xiao, Sa; Zhu, Hai; Zhu, Yi; Fang, Wenfeng; Zhang, Li; Yang, Yunpeng Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 10, pp. 893-902. DOI: 10.1200/JCO-25-01929 PubMed DOI |
| 2. | Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen Imaging Author: Zhang, Yunfeng; Wang, Xing; Hu, Honglin Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 10, pp. 945-946. DOI: 10.1200/JCO-25-02107 PubMed DOI |
| 3. | Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study Author: Robertson, John F. R.; Gogitidze, Teimuraz; Katashvili, Zaza; Rocha, Juan Enrique Bargallo; Arkania, Ekaterine; Moppett, Iain; Cheung, Kwok-Leung; Nemsadze, Gia; Ajimi, Maxine; Klinowska, Teresa; Lindemann, Justin P. O.; Mathewson, Alastair; Morrow, Christopher J.; Nikolaou, Myria; Scaltriti, Maurizio; Sykes, Andy; Dzagnidze, Giorgi Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 9, pp. 750-761. DOI: 10.1200/JCO-25-01548 PubMed DOI |
| 4. | International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR Author: Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C.; Minchom, Anna; Pe, Madeline; Peipert, John D.; Snyder, Claire; Symeonides, Stefan N.; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E.; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R.; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Donal; Le Tourneau, Christophe; Lee, J. Jack; Ma, Brigette B. Y.; Marshall, Lynley V.; Patel, Sheetal; Petrie, Joan; Pond, Gregory R.; Prior, Kieran; Rantell, Khadija R.; Reeve, John F.; Solovyeva, Olga; Wages, Nolan A.; Weber, Harald A.; Calvert, Melanie J.; Yap, Christina Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 8, pp. -. DOI: 10.1200/JCO-25-01625 PubMed DOI |
| 5. | Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer Author: Goss, Glenwood D.; Darling, Gail E.; Westeel, Virginie; Nakagawa, Kazuhiko; Massuti, Bartomeu; Perrone, Francesco; McLachlan, Sue-Anne; Kang, Jin Hyoung; Wu, Yi-Long; Dingemans, Anne-Marie C.; Dziadziuszko, Rafal; Greillier, Laurent; Okada, Morihito; Audigier-Valette, Clarisse; Sugawara, Shunichi; Nadal, Ernest; Catino, Annamaria; Toffart, Anne-Claire; Mitsudomi, Tetsuya; Whittom, Renaud; Domine, Manuel; Yamamoto, Nobuyuki; Molinier, Olivier; Morin, Franck; Bradbury, Penelope A.; Stockler, Martin R.; Ding, Keyue; O'Callaghan, Christopher J Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 7, pp. -. DOI: 10.1200/JCO-25-01828 PubMed DOI |
| 6. | Blind Spots in REZILIENT-1: Does Post-Platinum Zipalertinib Address Needs in Epidermal Growth Factor Receptor ex20ins+Non-Small Cell Lung Cancer? Author: Yao, Wenjian; Zhou, Qianjun; Shi, Taotao; Xu, Lei; Luo, Lei; Jia, Xiangbo; Wei, Li Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 7, pp. -. DOI: 10.1200/JCO-25-01501 PubMed DOI |
| 7. | Randomized Parallel-Group Phase II Study (NEOTERIC) of Atezolizumab With or Without Tiragolumab After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Author: Tang, Wentao; Wu, Aiwen; Lan, Ping; Ding, Kefeng; Wang, Zhenning; Wang, Jian; Chen, Nan; Wu, Xianrui; Jiao, Yurong; Liu, Funan; Tong, Lin; Shi, Yanjun; Xu, Jianmin Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 7, pp. -. DOI: 10.1200/JCO-25-01883 PubMed DOI |
| 8. | Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Author: Woyach, Jennifer A.; Qiu, Lugui; Grosicki, Sebastian; Wrobel, Tomasz; Capra, Marcelo; Czyz, Jaroslaw; Yi, Shuhua; Eom, Ki-Seong; Panovska, Anna; Jurczak, Wojciech; Laribi, Kamel; Jacobasch, Lutz; Baker, Ross; Agajanian, Richy; Berkovits, Alejandro; Ozcan, Muhit; Lepretre, Stephane; Coombs, Catherine C.; Cramer, Paula; Lewis, Katharine L.; Hill, Marisa; Bao, Katherine; Bian, Yuanyuan; De Batista Ribeiro, Silvia Ramalho; Bhandari, Naleen Raj; Ruppert, Amy S.; Leow, Ching Ching; Wierda, William G Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 6, pp. -. DOI: 10.1200/JCO-25-02477 PubMed DOI |
| 9. | Methodologic and Reporting Gaps in the SURF Trial Author: Shi, Qi; Wang, Yao; Hou, Fenggang Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 6, pp. 511-512. DOI: 10.1200/JCO-25-01687 PubMed DOI |
| 10. | NeoADAURA: Can We Afford to Overlook Objective Response Rates? Author: Fan, Dan; Zeng, Yue; Wu, Fang Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 5, pp. -. DOI: 10.1200/JCO-25-01336 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共117条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
